Quadruple Oral Combination Therapy for Type 2 Diabetes Mellitus : Glycemic Control by Thiazolidinedione (TZD) or Sodium Glucose Co-transporter 2 (SGLT-2) Inhibitor as an add-on Therapy in Type 2 Diabetes Mellitus After Failure of an Oral Triple Antidiabetic Regimen

NCT04013581 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
121
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Yonsei University